26 studies found for:    Open Studies | "Gout"
Hide Display Options

Display Options

Study Details
Participant Details
Identifiers
Dates
Rank Status Study
1 Unknown  Study of Levotofisopam 50 mg Three Times a Day (TID) Administered for 7 Days on Hyperuricemia and Gout
Conditions: Hyperuricemia;   Gout
Intervention: Drug: levotofisopam
2 Not yet recruiting Colchicine Or Naproxen Treatment for ACute gouT
Condition: Gout
Interventions: Drug: Low-dose colchicine;   Drug: Naproxen
3 Recruiting DECT Study in Allopurinol-Treated Gout Patients
Condition: Gout
Intervention: Procedure: DECT scan
4 Recruiting Phase 2 Study of URC102 to Assess the Efficacy and Safety in Gout Patients
Conditions: Gout;   Hyperuricemia
Interventions: Drug: URC102 0.25mg;   Drug: URC102 0.5mg;   Drug: URC102 1.0mg;   Drug: URC102 2.0mg;   Drug: placebo
5 Recruiting The Influence of Antiphospholipid Antibodies on the Relationship Between Hyperurecemia, Gout and Metabolic Syndrome
Conditions: Antiphospholipid Syndrome;   Endothelial Dysfunction;   Hyperuricemia;   Gout;   Metabolic Syndrome
Intervention:
6 Recruiting Efficacy and Safety of Extended Release and Immediate Release Febuxostat in Participants With Gout
Condition: Gout
Interventions: Drug: Febuxostat IR;   Drug: Febuxostat XR;   Drug: Febuxostat placebo;   Drug: Colchicine;   Drug: Naproxen;   Drug: Lansoprazole
7 Recruiting Efficacy and Safety of Extended Release and Immediate Release Febuxostat in Participants With Gout and Moderate Renal Impairment
Conditions: Gout;   Moderate Renal Impairment
Interventions: Drug: Febuxostat IR;   Drug: Febuxostat XR;   Drug: Febuxostat placebo;   Drug: Colchicine;   Drug: Naproxen;   Drug: Lansoprazole
8 Recruiting Observational Study of the Use of KRYSTEXXA® in Refractory Chronic Gout
Condition: Chronic Gout
Intervention: Biological: pegloticase
9 Recruiting A Study of AC-201 Controlled-Release Tablet (CR Tablet) in Patients With Gout
Condition: Gout
Interventions: Drug: Placebo;   Drug: AC-201;   Drug: Febuxostat
10 Recruiting Genetics of Hyperuricemia Therapy in Hmong
Condition: Hyperuricemia, Gout
Intervention: Drug: Allopurinol
11 Recruiting Rheumatology Informatics System for Effectiveness
Conditions: Rheumatoid Arthritis;   Osteoarthritis;   Gout
Intervention:
12 Recruiting Impact of Unapproved Drug Initiative on Colchicine Use
Condition: Gout
Intervention:
13 Recruiting Purine Metabolism Enzyme SNP to Uric Acid Production
Conditions: Gout;   Hyperuricemia
Intervention:
14 Recruiting Safety & Efficacy of Canakinumab (ACZ885) in Patients With Frequent Flares for Whom Nonsterodial Anti-Inflammatory Drug (NSAIDs) and/ or Colchicine Are Contraindicated, Not Tolerated or Ineffective
Condition: Gouty Arthritis
Interventions: Drug: Canakinumab, ACZ885;   Drug: Triamcinolone acetonide
15 Recruiting Regulatory B Cells in Inflammatory Rheumatisms and Biomarkers of Response to Biologic Treatments
Conditions: Rheumatoid Arthritis;   Osteoarthritis;   Systemic Lupus Erythematosus;   Sjogren's Syndrome;   Scleroderma;   Spondylitis;   Gout;   Spinal Disease;   Chondrocalcinosis
Intervention:
16 Recruiting Effects of Fasting on Self Efficacy
Conditions: Chronic Pain;   Fibromyalgia;   Rheumatoid Arthritis;   Gout;   Headache;   Arthritis;   Gastrointestinal Diseases;   Irritable Bowel Syndrome;   Inflammatory Bowel Disease;   Cardiovascular Diseases
Intervention: Behavioral: Fasting
17 Not yet recruiting Prospective Analgesic Compound Efficacy (PACE) Study
Conditions: Arthritis;   Tendonitis;   Gout;   Radiculopathy;   Muscle Spasms;   Synovitis;   Migraine;   Headache
Interventions: Drug: baclofen 2%;   Drug: Bupivacaine hydrochloride 1%;   Drug: Cyclobenzaprine hydrochloride 2%;   Drug: Diclofenac Sodium 3%;   Drug: Flurbiprofen 10%;   Drug: Gabapentin 6%;   Drug: Ketamine 10%;   Drug: Lidocaine 2%;   Drug: Prilocaine 2.5%;   Drug: Meloxicam 0.09%;   Drug: Sumatriptan 5%;   Drug: Tizanidine 0.1%;   Drug: Topiramate 2.5%;   Drug: Capsaicin, USP 0.0375%;   Drug: Menthol, NF 5.00 %
18 Recruiting Mild, Moderate and Severe Renal Impairment Study
Condition: Gout
Intervention: Drug: RDEA3170
19 Recruiting Effects of Hyperuricemia Reversal on Features of the Metabolic Syndrome
Condition: Gout
Intervention: Drug: Febuxostat
20 Recruiting Food Effect Study of Febuxostat XR in Healthy Participants
Condition: Gout
Interventions: Drug: Febuxostat XR 40 mg;   Drug: Febuxostat XR 80 mg

   Previous Page Studies Shown (1-20) Next Page (21-26) Show next page of results    Last Page
Indicates status has not been verified in more than two years